InsideArbitrage Event Driven Monitor – November 5, 2025
Merger Arbitrage
- EVOK: The acquisition of Evoke Pharma, Inc. (EVOK) by QOL Medical, LLC for a closing value of $6.35 million. QOL Medical, through a subsidiary, will initiate a tender offer to acquire all outstanding shares of Evoke for $11 per share in cash, which is at a premium of 139.65% from the stock’s last close. (Press Release)
- MTSR: Metsera (MTSR) said its board found Novo Nordisk’s (NVO) revised $10 billion offer of $62.20 per share in cash plus up to $24 per share in CVRs to be a “Superior Company Proposal.” Pfizer (PFE) has two business days to respond after recently raising its bid to $60 cash plus up to $10 per share in CVRs.
- BRY: Berry (BRY) filed a definitive proxy statement. The special meeting of shareholders will be held on December 15, 2025.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
